6:12 PM
 | 
May 14, 2009
 |  BC Extra  |  Company News

sanofi-aventis licenses Kyowa mAb

Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) granted sanofi-aventis Group (Euronext:SAN; NYSE:SNY) exclusive, worldwide rights to develop and commercialize...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >